International Vaccine Institute strategic demand forecasting; and Sabin – communications and advocacy. Besides leading the consortium, IVI generated evidence for decision-making such as disease burden, country vaccine introduction cases and a global investment case. From 2010 to 2016, DVI operated in Brazil, Burkina Faso, Cambodia, Colombia, Gabon, India, Kenya, Thailand, and Vietnam. From 2013-2015, with funding from Germany’s Federal Ministry of Education & Research (BMBF), IVI continued support for preclinical development of dengue vaccines by Brazil’s Butantan Institute and Vietnam’s VaBiotech. After the 2016 licensure of Sanofi Pasteur’s Dengvaxia vaccine, the DVI project came to a close and its IVI staff transitioned to
American Institute in Taiwan new $250 million compound for the American Institute in Taiwan was unveiled in June 2018, accompanied by a "low-key" American delegation and several mid-level diplomats. "See" "AIT Commercial Section" American Institute in Taiwan The American Institute in Taiwan (AIT; ) is a government-linked non-profit organization established under the auspices of the United States government to serve its interests in Taiwan. Primarily staffed by employees of the United States Department of State and local workers, AIT is a "de facto" embassy providing services normally provided by a United States diplomatic mission. The establishment of diplomatic relations with the People's Republic of